Visken Drug Information

Browse eMedTV's wide range of articles related to visken drug information including topics such as generic visken, visken dosage, and visken side effects. Use the search box at the top-right corner of the page to find information about other health topics.

 Read About 
Select a link from this list to read the article, or scroll down to see a short description of each article.
 
Description of Articles in Visken Drug Information

Visken is a beta blocker medicine often prescribed for the treatment of high blood pressure. This eMedTV Web page explains how the medication works and offers a more in-depth look at the drug's effects, dosing guidelines, and potential side effects.

Common side effects of Visken include joint pain, muscle pain, and water retention. This eMedTV resource lists other common side effects, rare but possible problems, and potentially serious side effects that require medical attention.

Visken is approved to treat high blood pressure. This article from the eMedTV Web site discusses the uses of Visken in more detail (including possible off-label uses), describes how the drug works, and explains whether it can be used in children.

The recommended starting dose of Visken for treating high blood pressure in most people is 5 mg twice daily. This eMedTV Web page offers more detailed dosing information, including how to safely stop using this medication.

Drugs that may cause potentially dangerous interactions with Visken include clonidine and digoxin. This eMedTV segment explores the potential risks of these and other interactions with the beta blocker medication.

If you have diabetes, tell your doctor before you start Visken. This eMedTV segment lists other warnings and precautions with Visken, including information on who should avoid this drug (such as those with severe heart failure).

Although brand-name Visken (pindolol) is no longer available, the drug is available in generic form. This eMedTV article lists the various forms and strengths of generic Visken and explains whether these products are equivalent to the brand-name drug.